Obesity and coronary risk in patients treated with second-generation antipsychotics (Q35074667)

6 August 2017

Obesity and coronary risk in patients treated with second-generation antipsychotics (English)

1 reference

6 August 2017

1

Christoph U Correll

1 reference

6 August 2017

2

John M Kane

1 reference

6 August 2017

Peter Manu

3

1 reference

6 August 2017

12 December 2010

1 reference

European Archives of Psychiatry and Clinical Neuroscience

6 August 2017

1 reference

6 August 2017

261

1 reference

6 August 2017

417-423

1 reference

6 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-010-0177-z

6 August 2017

0 references

cites work

Impact of tobacco smoking on lipid metabolism, body weight and cardiometabolic risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Schizophrenia and increased risks of cardiovascular disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Insulin resistance syndrome, body mass index and the risk of ischemic heart disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Consensus development conference on antipsychotic drugs and obesity and diabetes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

The impact of weight gain on quality of life among persons with schizophrenia.

8 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Central obesity and multivariable cardiovascular risk as assessed by the Framingham prediction scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

The metabolically healthy but obese individual presents a favorable inflammation profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Predictors of insulin resistance in the obese with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Obesity as a risk factor for antipsychotic noncompliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-010-0177-Z

Metabolic parameters in the short- and long-term treatment of schizophrenia with sertindole or risperidone.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

The distribution of body mass index among individuals with and without schizophrenia.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3125452

The seven countries study: 2,289 deaths in 15 years

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21153653

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Risk factors for coronary artery disease in old persons in an academic hospital-based geriatrics practice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21153653

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00406-010-0177-Z

1 reference

release_sfrkl5nft5fenftsdauyzpkbju

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sfrkl5nft5fenftsdauyzpkbju

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

3125452

1 reference

6 August 2017

1 reference

PubMed ID

21153653